Loading...
•
Jun 30, 2024
Abbott Q2 2024 Earnings Report
Abbott's Q2 2024 earnings were reported, revealing sales of $10.4 billion driven by strong underlying base business performance.
Key Takeaways
Abbott reported strong Q2 2024 results, with sales reaching $10.4 billion. The company's performance was driven by its underlying base business, particularly Medical Devices, which experienced double-digit growth. Abbott raised its full-year EPS and narrowed its organic sales growth guidance.
GAAP diluted EPS was $0.74, and adjusted diluted EPS was $1.14.
Full-year 2024 EPS guidance was raised to $3.30 to $3.40 on a GAAP basis and $4.61 to $4.71 on an adjusted basis.
Full-year 2024 organic sales growth guidance, excluding COVID-19 testing-related sales, was narrowed to 9.5% to 10.0%.
The company continues to strengthen its portfolio with new product approvals, including the Esprit™ BTK system and FDA clearance for Lingo™ and Libre Rio™.
Abbott
Abbott
Abbott Revenue by Segment
Abbott Revenue by Geographic Location
Revenue by Segment
Nutrition Revenue
CapyFin.comDiagnostics Revenue
CapyFin.comEstablished Pharma Revenue
CapyFin.comMedical Devices Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Abbott projects full-year 2024 diluted earnings per share under GAAP of $3.30 to $3.40. Excluding specified items, projected adjusted diluted earnings per share would be $4.61 to $4.71 for the full-year 2024. Abbott projects third-quarter 2024 diluted earnings per share under GAAP of $0.85 to $0.89. Excluding specified items, projected adjusted diluted earnings per share would be $1.18 to $1.22 for the third quarter 2024.
Positive Outlook
- Full-year 2024 diluted EPS on a GAAP basis is projected to be $3.30 to $3.40.
- Adjusted diluted EPS for the full-year 2024 is projected to be $4.61 to $4.71.
- Third-quarter 2024 diluted earnings per share under GAAP is projected to be $0.85 to $0.89.
- Adjusted diluted earnings per share for the third quarter 2024 is projected to be $1.18 to $1.22.
Revenue & Expenses
Visualization of income flow from segment revenue to net income